Amgen Inc. buy Piper Sandler
Start price
02.01.25
/
50%
€254.50
Target price
02.01.26
€300.51
Performance (%)
8.92%
End price
03.01.26
€277.20
Summary
This prediction ended on 03.01.26 with a price of €277.20. With a performance of 8.92%, the BUY prediction by Piper_Sandler for Amgen Inc. closed with a slight gain. Piper_Sandler has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €9.41 are taken into consideration when calculating the performance. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 3.747% | 3.747% | 26.709% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Piper_Sandler for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Piper Sandler from $344.00 to $310.00. They now have an "overweight" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten